SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is currently seeing increased market interest as investors react to the latest industry-wide AI infrastructure updates and product announcements regarding NVIDIA's new hardware architectures. Despite this, the community remains divided, with active debates centered on the stock's recent price consolidation, skepticism regarding management's transparency, and frustration over the company's inability to maintain a sustained upward trend.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is capturing intense investor attention as its critical role in satellite imagery for defense and geopolitical monitoring aligns with increasing government contract demand. While some community members are focused on price volatility and technical setups, many are bullish on its long-term potential as a key player in the evolving space-based intelligence sector.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is capturing attention as community members debate its long-term potential ahead of the Super App launch and high-profile industry events like the upcoming XRP Las Vegas conference. Investors are actively discussing the impact of imminent token unlocks, upcoming institutional partnerships, and the project's push into real-world payment infrastructure as they weigh the risks and rewards of accumulating at current levels.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXT Inc. is currently seeing extreme volatility and heightened investor scrutiny as traders debate whether its recent parabolic move is a sustainable play on the indium phosphide supply chain bottleneck or an unsustainable pump-and-dump. While bullish investors point to its critical role in the optical infrastructure required for AI data centers, skeptics are actively targeting the stock, citing aggressive insider selling, an underwhelming revenue-to-market-cap ratio, and the constant threat of a dilutive equity offering.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors await the final analysis of its pivotal Phase 3 REGAL trial, with community discussion intensely focused on whether the lack of an 80th-event announcement signals durable patient survival indicative of a curative breakthrough. While some traders are expressing skepticism over the timeline and lack of recent conference calls, many longs are highlighting the company's strong cash position and the potential for a transformative valuation re-rating if the trial data succeeds.

Dogelon Mars

Dogelon Mars is generating significant community buzz as holders track recent liquidity developments and speculate on potential partnerships, though sentiment remains heavily polarized between long-term bulls and skeptical investors frustrated by extended price stagnation. The discourse is fueled by a mix of high-conviction "diamond hand" narratives, hopes for token burns to catalyze growth, and vocal criticism regarding the project's historical performance compared to other meme coin assets.

FedEx Corp. is a holding company, which engages in the provision of transportation, e-commerce, business services, and business solutions. It operates through the following segments: FedEx Express, FedEx Freight, Corporate, Other, and Eliminations. The FedEx Express segment offers transportation and delivery services. The FedEx Freight segment refers to freight transportation services to business and residences. The FedEx Services segment includes sales, marketing, information technology, communications, customer service, technical support, billing and collection services, and certain back-office functions that support the company's operating segments. The Corporate, Other, and Eliminations segment is involved in the corporate headquarters costs for executive officers and certain legal and finance functions, as well as certain other costs and credits not attributed to the firm's core business. The company was founded by Frederick Wallace Smith on June 18, 1971, and is headquartered in Memphis, TN.

Fedex Corp

FedEx is attracting significant investor attention following a solid earnings beat and raised full-year guidance, with the community actively debating the impact of the planned Freight business spin-off and broader shipping demand. While bullish participants point to disciplined cost-cutting and domestic growth as key drivers, skeptics are expressing caution regarding geopolitical risks and potential margin pressure from volatile fuel and freight costs.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is currently trending as shareholders and political observers express intense frustration over the stock's significant decline, often linking the market performance to broader concerns regarding geopolitical instability and the company's financial results. Community discussion remains highly polarized, with users clashing over the company's long-term viability, the impact of federal policy, and the ongoing political narratives surrounding the platform's association with Donald Trump.

Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. It is also involved in the clinical development program for setmelanotide in other rare MC4R pathway diseases, as well as a preclinical suite of investigational candidates for the treatment of congenital hyperinsulinism. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.

Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals is trending due to the FDA's approval of an expanded indication for IMCIVREE, allowing the treatment of patients as young as two years old. The community is actively discussing the potential revenue growth from this label extension, the company's strong clinical pipeline, and ongoing speculation regarding its long-term potential as a key acquisition target in the rare disease space.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending following a massive $1.25 billion partnership with Uber to deploy a fleet of autonomous robotaxis by 2028, sparking significant debate regarding the company's long-term scaling potential and ability to meet ambitious milestones. Investors and community members remain sharply divided, with bulls pointing to the company's growing ecosystem of partnerships as evidence of institutional validation, while skeptics emphasize persistent concerns over cash burn and production timelines.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.

ANGN
Angion Biomedica Corp

Feed

News

Sentiment

Fundamentals

Info

Latest ANGN News

ANGNAngion Biomedica Corp